281
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Up-Regulation of ProBDNF/p75NTR Signaling in Spinal Cord Drives Inflammatory Pain in Male Rats

ORCID Icon, , , ORCID Icon, , , , , & show all
Pages 95-107 | Received 23 Aug 2022, Accepted 20 Dec 2022, Published online: 09 Jan 2023

References

  • Ruskin DN, Sturdevant IC, Wyss LS, Masino SA. Ketogenic diet effects on inflammatory allodynia and ongoing pain in rodents. Sci Rep. 2021;11(1):725. doi:10.1038/s41598-020-80727-x
  • Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267–284. doi:10.1016/j.cell.2009.09.028
  • Xiang X, Wang S, Shao F, et al. Electroacupuncture stimulation alleviates CFA-induced inflammatory pain via suppressing P2X3 expression. Int J Mol Sci. 2019;20:13. doi:10.3390/ijms20133248
  • Westin BD, Walker SM, Deumens R, Grafe M, Yaksh TL. Validation of a preclinical spinal safety model: effects of intrathecal morphine in the neonatal rat. Anesthesiology. 2010;113(1):183–199. doi:10.1097/ALN.0b013e3181dcd6ec
  • Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821–847. doi:10.18433/J3VW2F
  • Shen WY, Luo C, Hurtado PR, et al. Up-regulation of proBDNF/p75(NTR) signaling in antibody-secreting cells drives systemic lupus erythematosus. Sci Adv. 2022;8(3):eabj2797. doi:10.1126/sciadv.abj2797
  • Johnson D, Lanahan A, Buck CR, et al. Expression and structure of the human NGF receptor. Cell. 1986;47(4):545–554. doi:10.1016/0092-8674(86)90619-7
  • Radeke MJ, Misko TP, Hsu C, Herzenberg LA, Shooter EM. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature. 1987;325(6105):593–597. doi:10.1038/325593a0
  • Hu ZL, Luo C, Hurtado PR, et al. Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis. Theranostics. 2021;11(2):715–730. doi:10.7150/thno.51390
  • Luo RY, Luo C, Zhong F, et al. ProBDNF promotes sepsis-associated encephalopathy in mice by dampening the immune activity of meningeal CD4(+) T cells. J Neuroinflammation. 2020;17(1):169. doi:10.1186/s12974-020-01850-0
  • Shen WY, Luo C, Reinaldo Hurtado P, et al. The regulatory role of ProBDNF in monocyte function: implications in Stanford type-A aortic dissection disease. FASEB j. 2020;34(2):2541–2553. doi:10.1096/fj.201901905RR
  • Kelliny S, Lam HY, Parikh A, et al. Preclinical study of the pharmacokinetics of p75ECD-Fc, a novel human recombinant protein for treatment of alzheimer’s disease, in Sprague Dawley rats. Curr Drug Metab. 2020;21(3):235–244. doi:10.2174/1389200221666200502015203
  • Luo C, Zhong XL, Zhou FH, et al. Peripheral brain derived neurotrophic factor precursor regulates pain as an inflammatory mediator. Sci Rep. 2016;6:27171. doi:10.1038/srep27171
  • Bai YY, Ruan CS, Yang CR, et al. ProBDNF signaling regulates depression-like behaviors in rodents under chronic stress. Neuropsychopharmacology. 2016;41:12. doi:10.1038/npp.2016.100
  • Le BD, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597–652.
  • Xu J, Chen XM, Zheng BJ, Wang XR. Electroacupuncture relieves nerve injury-induced pain hypersensitivity via the inhibition of spinal P2X7 receptor-positive microglia. Anesth Analg. 2016;122(3):882–892. doi:10.1213/ANE.0000000000001097
  • Taliyan R, Sharma PL. Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats. Inflammopharmacology. 2012;20(2):89–97. doi:10.1007/s10787-011-0106-4
  • Chen XM, Xu J, Song JG, Zheng BJ, Wang XR. Electroacupuncture inhibits excessive interferon-gamma evoked up-regulation of P2X4 receptor in spinal microglia in a CCI rat model for neuropathic pain. Br J Anaesth. 2015;114(1):150–157. doi:10.1093/bja/aeu199
  • Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55–63. doi:10.1016/0165-0270(94)90144-9
  • Wang Z, Wu JL, Zhong F, et al. Upregulation of proBDNF in the mesenteric lymph nodes in septic mice. Neurotox Res. 2019;36(3):540–550. doi:10.1007/s12640-019-00081-3
  • Sakurai J, Obata K, Ozaki N, et al. Activation of extracellular signal-regulated protein kinase in sensory neurons after noxious gastric distention and its involvement in acute visceral pain in rats. Gastroenterology. 2008;134(4):1094–1103. doi:10.1053/j.gastro.2008.01.031
  • Luo JG, Zhao XL, Xu WC, et al. Activation of spinal NF-kappaB/p65 contributes to peripheral inflammation and hyperalgesia in rat adjuvant-induced arthritis. Arthritis Rheumatol. 2014;66(4):896–906. doi:10.1002/art.38328
  • Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G. BDNF as a Promising Therapeutic Agent in Parkinson’s Disease. Int J Mol Sci. 2020;21:3. doi:10.3390/ijms21031170
  • Cui YH, Zhou SF, Liu Y, et al. Injection of anti-probdnf attenuates hippocampal-dependent learning and memory dysfunction in mice with sepsis-associated encephalopathy. Front Neurosci. 2021;15:665757. doi:10.3389/fnins.2021.665757
  • Ferrini F, Trang T, Mattioli TA, et al. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl(-) homeostasis. Nat Neurosci. 2013;16(2):183–192. doi:10.1038/nn.3295
  • Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ, McMahon SB. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci U S A. 1999;96(14):7714–7718. doi:10.1073/pnas.96.14.7714
  • Ha SO, Kim JK, Hong HS, Kim DS, Cho HJ. Expression of brain-derived neurotrophic factor in rat dorsal root ganglia, spinal cord and gracile nuclei in experimental models of neuropathic pain. Neuroscience. 2001;107(2):301–309. doi:10.1016/S0306-4522(01)00353-0
  • Li CQ, Xu JM, Dan L, Zhang JY, Dai RP. Brain derived neurotrophic factor (BDNF) contributes to the pain hypersensitivity following surgical incision in the rats. Mol Pain. 2008;4(1):27. doi:10.1186/1744-8069-4-27
  • Zhou LJ, Peng J, Xu YN, et al. Microglia are indispensable for synaptic plasticity in the spinal dorsal horn and chronic pain. Cell Rep. 2019;27(13):3844–3859 e3846. doi:10.1016/j.celrep.2019.05.087
  • Wang H, Wei Y, Pu Y, et al. Brain-derived neurotrophic factor stimulation of T-type Ca(2+) channels in sensory neurons contributes to increased peripheral pain sensitivity. Sci Signal. 2019;12:600. doi:10.1126/scisignal.aaw2300
  • Coull JA, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438(7070):1017–1021. doi:10.1038/nature04223
  • Lin YT, Ro LS, Wang HL, Chen JC. Up-regulation of dorsal root ganglia BDNF and trkB receptor in inflammatory pain: an in vivo and in vitro study. J Neuroinflammation. 2011;8:126. doi:10.1186/1742-2094-8-126
  • Fujii T, Kunugi H. p75NTR as a therapeutic target for neuropsychiatric diseases. Curr Mol Pharmacol. 2009;2(1):70–76. doi:10.2174/1874467210902010070
  • Kisiswa L, Fernández-Suárez D, Sergaki MC, Ibáñez CF. RIP2 Gates TRAF6 interaction with death receptor p75(NTR) to regulate cerebellar granule neuron survival. Cell Rep. 2018;24(4):1013–1024. doi:10.1016/j.celrep.2018.06.098
  • Fukui Y, Ohtori S, Yamashita M, et al. Low affinity NGF receptor (p75 neurotrophin receptor) inhibitory antibody reduces pain behavior and CGRP expression in DRG in the mouse sciatic nerve crush model. J Orthop Res. 2010;28(3):279–283. doi:10.1002/jor.20986
  • Gonçalves NP, Jager SE, Richner M, et al. Schwann cell p75 neurotrophin receptor modulates small fiber degeneration in diabetic neuropathy. Glia. 2020;68(12):2725–2743. doi:10.1002/glia.23881
  • Fang J, Wei Z, Zheng D, et al. Recombinant extracellular domain (p75ECD) of the neurotrophin receptor p75 attenuates myocardial ischemia-reperfusion injury by inhibiting the p-JNK/Caspase-3 signaling pathway in rat microvascular pericytes. J Am Heart Assoc. 2020;9(13):e016047. doi:10.1161/JAHA.119.016047
  • Yao XQ, Jiao SS, Saadipour K, et al. p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer’s disease. Mol Psychiatry. 2015;20(11):1301–1310. doi:10.1038/mp.2015.49
  • Hirose M, Kuroda Y, Murata E. NGF/TrkA Signaling as a Therapeutic Target for Pain. Pain Practice. 2016;16(2):175–182. doi:10.1111/papr.12342
  • Patel MK, Kaye AD, Urman RD. Tanezumab: therapy targeting nerve growth factor in pain pathogenesis. J Anaesthesiol Clin Pharmacol. 2018;34(1):111–116. doi:10.4103/joacp.JOACP_389_15
  • Norman BH, McDermott JS. Targeting the Nerve Growth Factor (NGF) pathway in drug discovery. potential applications to new therapies for chronic pain. J Med Chem. 2017;60(1):66–88. doi:10.1021/acs.jmedchem.6b00964
  • Li F, Zhang JW, Wei R, et al. Sex-differential modulation of visceral pain by brain derived neurotrophic factor (BDNF) in rats. Neurosci Lett. 2010;478(3):184–187. doi:10.1016/j.neulet.2010.05.013